[A study of combined chemotherapy with MMC, ADM, CDDP, VP-16 and 5'DFUR (MAC-VD) in advanced cancers of digestive organs].
Yasutake
K
K
Hyogo Medical Center for Adults, Dept. of gastroenterology.
Imamura
Y
Y
Yoshimura
Y
Y
Oya
M
M
Matsusita
K
K
Tokisue
M
M
Okutani
T
T
Ono
S
S
D000284:Administration, Oral; D000328:Adult; D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002945:Cisplatin / Q000008:administration & dosage; D003110:Colonic Neoplasms / Q000188:drug therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D004334:Drug Administration Schedule; D005047:Etoposide / Q000008:administration & dosage; D005260:Female; D005467:Floxuridine / Q000008:administration & dosage; D005706:Gallbladder Neoplasms / Q000188:drug therapy; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D013160:Splenic Neoplasms / Q000188:drug therapy; D013274:Stomach Neoplasms / Q000188:drug therapy*
D008937:Mitomycins; D005467:Floxuridine; D016685:Mitomycin; D005047:Etoposide; D004317:Doxorubicin; D002945:Cisplatin; C025034:doxifluridine